Brief: Elicera Therapeutics Q3 Operating Loss Narrows To SEK 5.1 Million
Nov 14 (Reuters) - Elicera Therapeutics AB ELIC.ST :
* Q3 OPERATING LOSS SEK 5.1 MILLION VERSUS LOSS SEK 7.0
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr57nKV7
Further company coverage: ELIC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Elicera Therapeutics Completes Phase I Part Of Carma Study
Brief: Elicera Therapeutics Gets Medical Products Agency Approval To Advance CARMA Study
Brief: Elicera Gets Clearance To Use Highest ELC-301 Dose Ahead Of Phase IIa
Brief: Elicera Gets First Patent Allowance For ELC-201
Brief: Elicera Receives Notice Of Allowance For U.S. Patent Application